NCT04231877 Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04221789 TB Treatment Support Tool Interactive Mobile App and Direct Adherence Monitoring on TB Treatment Outcomes Status ACTIVE_NOT_RECRUITING Phase NA
NCT04220229 Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities Status TERMINATED Phase PHASE1/PHASE2
NCT04216173 Acupuncture for Headache Post-Traumatic Brain Injury: A Feasibility Study Status TERMINATED Phase NA
NCT04213846 Alcohol & Mobile Phone Study to Reduce High-risk Alcohol Use and Consequences Status COMPLETED Phase NA
NCT04205409 Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT04199533 Iterative Redesign of a Behavioral Skills Training Program for Use in Educational Settings Status COMPLETED Phase N/A
NCT04196010 Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms Status TERMINATED Phase PHASE1
NCT04180956 Addressing Microaggressions in Racially Charged Patient-provider Interactions: A Pilot Randomized Trial Status COMPLETED Phase NA
NCT04175431 Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study Status RECRUITING Phase PHASE2
NCT04156828 Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma Status TERMINATED Phase PHASE1
NCT04155840 Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status TERMINATED Phase PHASE2
NCT04151940 PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer Status RECRUITING Phase NA